MedPath

Role of Immunoglobulin G (IgG) in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma

Not Applicable
Conditions
Health Condition 1: C069- Malignant neoplasm of mouth, unspecified
Registration Number
CTRI/2023/10/058282
Lead Sponsor
Sardar Patel Postgradute Institute of Dental and medical sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.clinically confirmed cases of OSMF2.histologically confirmed cases of OSCC

3.Healthy volunteers having no oral lesion and not having the habit of tobacco or alcohol uses

Exclusion Criteria

1.Patients receiving radiotherapy or chemotherapy

2.Patients under medications such as immunomodulators or immunosuppressors

3.Patients with bleeding disorders

4.Patients below the age group of 18 years

5.Patients suffering from autoimmune diseases

6.Physiological conditions such as pregnancy.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The possible outcome will be to know Corelation of serum IgG levels in clinically confirmed cases of OSMF & histologically confirmed cases of OSCC.Timepoint: 1 day
Secondary Outcome Measures
NameTimeMethod
IgG plays an important roles in OSMF & OSCC, may serve as a potential therapeutic target.Timepoint: 3 months
© Copyright 2025. All Rights Reserved by MedPath